Watchman for patients with atrial fibrillation undergoing transcatheter aortic valve replacement
This Study is
No Longer Enrolling
WATCH-TAVR is a prospective, multicenter, randomized event-driven controlled trial.
Adult
- Patient meets criteria for and is eligible to undergo TAVR procedure - Patient meets the WATCHMAN labeling guidelines and is eligible to undergo the WATCHMAN implantation procedure.
Not Applicable - Describes studies without FDA-defined phases, including studies of devices or behavioral interventions.
Treatment
Harmony Campus
Medical Center of the Rockies
Protocol Number: 18-6002
More information available at ClinicalTrials.gov: NCT03173534
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers